Genetic Variants of the IL-23R Pathway: Association with Psoriatic Arthritis and Psoriasis Vulgaris, but No Specific Risk Factor for Arthritis-Reference-Cited by-同舟云学术

Genetic Variants of the IL-23R Pathway: Association with Psoriatic Arthritis and Psoriasis Vulgaris, but No Specific Risk Factor for Arthritis

Published:2009-02 Issue:2 Volume:129 Page:355-358
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Hüffmeier Ulrike,Lascorz Jesús,Böhm Beate,Lohmann Jörg,Wendler Jörg,Mössner Rotraut,Reich Kristian,Traupe Heiko,Kurrat Werner,Burkhardt Harald,Reis André

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference19 articles.

1. Haploview: analysis and visualization of LD and haplotype maps;Barrett;Bioinformatics,2005

2. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants;Burton;Nat Genet,2007

3. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis;Capon;Hum Genet,2007

4. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes;Cargill;Am J Hum Genet,2007

5. Cytokine gene polymorphisms in Chinese patients with psoriasis;Chang;Br J Dermatol,2007

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Pathogenesis of Spondylarthritis beyond HLA-B27: A Descriptive Review;International Journal of Molecular Sciences;2024-05-31

2. Differences between psoriatic arthritis and psoriasis in multi-omics;Archives of Dermatological Research;2024-05-24

3. Redox Pathogenesis in Rheumatic Diseases;ACR Open Rheumatology;2024-04-25

4. Interleukin-23 receptor gene polymorphisms in osteoporosis;The European Research Journal;2023-11-04

5. Association of IL-23R (rs11209026 A/G) polymorphism with susceptibility to common autoimmune diseases: a meta-analysis combined with trial sequence analysis;2023-05-09